Sharon Mates Insider Profile

4 Followers
Sharon Mates, Chairman & CEO, Director at Intra-Cellular Therapies, holds 1.07M shares in Intra-Cellular Therapies (Ticker: ITCI).
tipranks
Sharon Mates

Sharon Mates
Intra-Cellular Therapies (ITCI)
Chairman & CEO, Director

Not Ranked
Sharon Mates has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$80M
100.00%
A breakdown of Sharon Mates's holdings

Insider Roles

Intra-Cellular Therapies
(ITCI)
Chairman & CEO, Director
Roles that Sharon Mates holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Sharon Mates

Sharon Mates's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intra-Cellular Therapies
Aug 30, 2024
Chairman & CEO, Director
Uninformative Buy
891.10K
$79.95M
Sharon Mates has not reported any informative transactions for ITCI, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 09, 2013
Uninformative Buy
-
$19.00
Jan 03, 2019
Uninformative Buy
$523.65K
-
$11.39
Jan 03, 2020
Uninformative Buy
$1.11M
-
$23.71
Jan 08, 2020
Uninformative Buy
$700.52K
-
$17.95
Jan 12, 2021
Uninformative Buy
$0.00
-
$32.48
List of latest transactions for each holding click on a transaction to see Sharon Mates's performance on stock

Sharon Mates insider profile FAQ

What is the percentage of profitable transactions made by Sharon Mates?
The percentage of profitable transactions made by Sharon Mates is ―.
    What is the average return per transaction made by Sharon Mates?
    The average return per transaction made by Sharon Mates is ―.
      What stocks does Sharon Mates hold?
      Sharon Mates holds: ITCI stocks.
        What was Sharon Mates’s latest transaction?
        Sharon Mates latest transaction was an Uninformative Buy of $891.10K.
          What was Sharon Mates's most profitable transaction?
          Sharon Mates’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Sharon Mates's role in Intra-Cellular Therapies?
            Sharon Mates's role in Intra-Cellular Therapies is Chairman & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.